MY139957A - Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-indol-3-yl-1h-pyrrole mono-hydrochloride - Google Patents

Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-indol-3-yl-1h-pyrrole mono-hydrochloride

Info

Publication number
MY139957A
MY139957A MYPI20022777A MY139957A MY 139957 A MY139957 A MY 139957A MY PI20022777 A MYPI20022777 A MY PI20022777A MY 139957 A MY139957 A MY 139957A
Authority
MY
Malaysia
Prior art keywords
indol
piperidin
ylmethyl
dione
crystalline
Prior art date
Application number
Inventor
Bush Julie Kay
Faul Margaret Mary
Reutzel-Edens Susan Marie
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to MYPI20022777 priority Critical patent/MY139957A/en
Priority to MYPI20032577 priority patent/MY138934A/en
Publication of MY139957A publication Critical patent/MY139957A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE PRESENT INVENTION RELATES TO CRYSTALLINE 2,5-DIONE-3-(1-METHYL-1H-INDOL-3-YL)-4-[1-(PYRIDINE-2-YLMETHYL)PIPERIDIN-4-YL]-1H-INDOL-3-YL]-1H-PYRROLE MONO-HYDROCHLORIDE SALT, A PHARMACEUTICAL FORMULATION CONTAINING SAID SALT AND TO METHODS FOR TREATING CANCER AND FOR INHIBITING TUMOR GROWTH USING SAID SALT.
MYPI20022777 2002-07-23 2002-07-23 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-indol-3-yl-1h-pyrrole mono-hydrochloride MY139957A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MYPI20022777 MY139957A (en) 2002-07-23 2002-07-23 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-indol-3-yl-1h-pyrrole mono-hydrochloride
MYPI20032577 MY138934A (en) 2002-07-23 2003-07-09 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20022777 MY139957A (en) 2002-07-23 2002-07-23 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-indol-3-yl-1h-pyrrole mono-hydrochloride

Publications (1)

Publication Number Publication Date
MY139957A true MY139957A (en) 2009-11-30

Family

ID=45699544

Family Applications (2)

Application Number Title Priority Date Filing Date
MYPI20022777 MY139957A (en) 2002-07-23 2002-07-23 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-indol-3-yl-1h-pyrrole mono-hydrochloride
MYPI20032577 MY138934A (en) 2002-07-23 2003-07-09 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride

Family Applications After (1)

Application Number Title Priority Date Filing Date
MYPI20032577 MY138934A (en) 2002-07-23 2003-07-09 Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride

Country Status (1)

Country Link
MY (2) MY139957A (en)

Also Published As

Publication number Publication date
MY138934A (en) 2009-08-28

Similar Documents

Publication Publication Date Title
HRP20050035B1 (en) Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
IL171976A0 (en) Indazole, benzisoxazole, and banzisothiazole kinase inhibitors
YU61402A (en) Pyrrole substituted 2-indolinone protein kinase inhibitors
TW200621715A (en) Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
AP9901478A0 (en) Compounds for the treatment of ischemia.
PL1618092T3 (en) Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
UA84712C2 (en) N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
PL364625A1 (en) N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
RS60404A (en) Controlled synthesis of ziprasidone and compositions thereof
ATE381557T1 (en) RHO KINASE INHIBITORS
RS20050116A (en) Novel phenanthridines
HK1085675A1 (en) Anticancer compounds
MXPA05009611A (en) SUBSTITUTED PIPERIDINES AS NOVEL MDM2-p53 INHIBITORS.
WO2003106450A8 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors
MXPA02000330A (en) Neurotrophic pyrrolidines and piperidines, and related compositions and methods.
WO2004058705A3 (en) Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor
MY139957A (en) Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-indol-3-yl-1h-pyrrole mono-hydrochloride
TW200503722A (en) Substituted 7-aza-quinazoline compounds
YU46302A (en) Substituted pyrroles
GB0223223D0 (en) Organic compounds
WO2002002116A3 (en) Therapeutic treatment of cancer with a protein kinase c inhibitor
AR034836A1 (en) 2,5-DIONA-3- MONO-CHLORHYDRATE (1-METHYL-1H-INDOL-3-IL) -4- [1- (PIRIDIN-2-ILMETIL) PIPERIDIN-4-IL) -1H-INDOL-3 -IL) -1H-CRYSTAL PIRROL.
BR0302183A (en) Compound, pharmaceutical composition and use of a compound
CR7650A (en) 2,5-DIONA-3 MONOCLORHYDRATE (-1METIL-1H-INDOL-3-iL) -4- [1- (PIRIDIN-2-ILMETIL) PIPERIDIN-4-iL) -1H-INDOL-3-iL)] -1H-CRYSTAL PIRROL
RS20050063A (en) Pyrrolidine derivatives as tryptase inhibitors